We confirm that brusatol decreased NRF2 protein (Figure 3) in human FLT3-ITD expressing cells, and a subsequent decrease in HO-1 protein levels, suggesting that HO-1 is a downstream target of NRF2 in ITD+ AML cells (Figure 3). The gene discussed is FLT3; the disease is acute myeloid leukemia.